Compile Data Set for Download or QSAR
maximum 50k data
Found 72 Enz. Inhib. hit(s) with all data for entry = 6926
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159835(US9040518, 68)
Affinity DataIC50:  1nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159822(US9040518, 46)
Affinity DataIC50:  2nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434847(CHEMBL2387421 | US9040518, 3)
Affinity DataIC50:  2nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159806(US9040518, 23)
Affinity DataIC50:  2nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159795(US9040518, 9)
Affinity DataIC50:  3nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434867(CHEMBL2387522 | US9040518, 20)
Affinity DataIC50:  4nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159793(US9040518, 5)
Affinity DataIC50:  4nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159808(US9040518, 25)
Affinity DataIC50:  6nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159831(US9040518, 64)
Affinity DataIC50:  6nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434865(CHEMBL2387511 | US9040518, 37)
Affinity DataIC50:  9nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434864(CHEMBL2387420 | US9040518, 2)
Affinity DataIC50:  11nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159823(US9040518, 47)
Affinity DataIC50:  13nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159796(US9040518, 10)
Affinity DataIC50:  17nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159824(US9040518, 48)
Affinity DataIC50:  17nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159836(US9040518, 69)
Affinity DataIC50:  19nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159797(US9040518, 11)
Affinity DataIC50:  20nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159833(US9040518, 66)
Affinity DataIC50:  21nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434849(CHEMBL2385105 | US9040518, 6)
Affinity DataIC50:  23nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434861(CHEMBL2387525 | US9040518, 1)
Affinity DataIC50:  32nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434859(CHEMBL2387398 | US9040518, 49)
Affinity DataIC50:  41nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM47370(BDBM50434858 | US9040518, 26)
Affinity DataIC50:  43nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159810(US9040518, 27)
Affinity DataIC50:  47nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159825(US9040518, 50)
Affinity DataIC50:  51nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434854(CHEMBL2387523 | US9040518, 51)
Affinity DataIC50:  51nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434853(CHEMBL2387524 | US9040518, 21)
Affinity DataIC50:  51nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159834(US9040518, 67)
Affinity DataIC50:  52nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434846(CHEMBL2387399 | US9040518, 35)
Affinity DataIC50:  54nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159811(US9040518, 28)
Affinity DataIC50:  55nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434851(CHEMBL2387419 | US9040518, 52)
Affinity DataIC50:  59nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159826(US9040518, 53)
Affinity DataIC50:  67nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159798(US9040518, 12)
Affinity DataIC50:  68nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159794(US9040518, 8)
Affinity DataIC50:  73nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159807(US9040518, 24)
Affinity DataIC50:  73nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159838(US9040518, 71)
Affinity DataIC50:  100nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159837(US9040518, 70)
Affinity DataIC50:  100nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159827(US9040518, 54)
Affinity DataIC50:  124nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434844(CHEMBL2387512 | US9040518, 42)
Affinity DataIC50:  128nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159828(US9040518, 55)
Affinity DataIC50:  131nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434840(CHEMBL2387405 | US9040518, 7)
Affinity DataIC50:  145nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434842(CHEMBL2387509 | US9040518, 13)
Affinity DataIC50:  167nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159809(US9040518, 32)
Affinity DataIC50:  190nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434839(CHEMBL2387513 | US9040518, 38)
Affinity DataIC50:  249nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159799(US9040518, 14)
Affinity DataIC50:  276nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159832(US9040518, 65)
Affinity DataIC50:  337nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434837(CHEMBL2387406 | US9040518, 36)
Affinity DataIC50:  365nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159812(US9040518, 29)
Affinity DataIC50:  367nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159813(US9040518, 31)
Affinity DataIC50:  407nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM50434835(CHEMBL2387418 | US9040518, 56)
Affinity DataIC50:  425nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159800(US9040518, 15)
Affinity DataIC50:  504nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
Glaxosmithkline

US Patent
LigandPNGBDBM159816(US9040518, 39)
Affinity DataIC50:  619nMT: 2°CAssay Description:On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The as...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 72 total ) | Next | Last >>
Jump to: